A popular antiviral drug developed by a major World Economic Forum-linked pharmaceutical company to treat Covid has been found to mutate the virus and cause it to spread rapidly, a new study has revealed.
The drug, Molnupiravir, is produced by German Big Pharma giant Merck in collaboration with Ridgeback Biotherapeutics.
Belén Garijo, the Chair of the Executive Board and CEO of Merck, is one of the World Economic Forum’s most senior Agenda Contributors, Slay News reports.
On Monday, the Express reported that the researchers behind the new study examined a staggering 15 million Covid sequences to determine how it has mutated over time.
Their findings have caused major cause for concern.
The analysis shows that there were mutations that deviated from the normal pattern of change.
Moreover, the researchers uncovered a disturbing pattern that indicates the cause of these abnormal changes.
They are now raising the alarm after discovering one-third of the mutations were directly linked to individuals who had taken Merck’s Molnupiravir antiviral drug.
Molnupiravir was one of the first antiviral drugs placed on the market to combat Covid.
The popular drug is used by patients in several countries around the world, including the United States.
The Express notes that Molnupiravir